Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy

Scientists examine the immunosuppressive features of the leukemia microenvironment, discuss how preclinical modeling help predict adoptive cell therapy (ACT) associated toxicities and dysfunction, and explore publications that have employed syngeneic modeling in ACT studies for the improvement of therapy for leukemias.